Company profile: Resistell
1.1 - Company Overview
Company description
- Provider of antibiotic resistance testing via Phenotech Multistar, an ultra-rapid Antibiotic Susceptibility Testing (AST) platform using nanomotion technology to deliver results in 2 hours independent of bacterial growth, and Phenotech Research, a research device measuring nanoscale cellular vibrations to study growth phenotypes and provide rapid test results.
Products and services
- Antibiotic Resistance Test: An AST-focused test determining bacterial resistance to antibiotics, reflecting Resistell’s core offering for evaluating susceptibility
- Phenotech Multistar: A nanomotion-based platform for ultra-rapid Antibiotic Susceptibility Testing (AST) delivering results in 2 hours, independent of bacterial growth
- Phenotech Research: A nanoscale-level research device measuring cellular vibrations, enabling study of various growth phenotypes and producing rapid test results
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Resistell
MorphoChem
HQ: Germany
Website
- Description: Provider of innovative intravenous therapy for Clostridium difficile infection (CDI), based on novel antibacterial MCB3681, addressing an unmet medical need and aiming to make a difference for CDI patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MorphoChem company profile →
Proof Diagnostics
HQ: United States
Website
- Description: Provider of life sciences tools, diagnostics, and computational discovery solutions, offering a smart, portable CRISPR-based and other technology diagnostic system for rapid, low-cost, sensitive detection of infectious diseases (e.g., SARS-CoV-2, Flu A/B, RSV) and other diseases, OMEGA libraries of RNA-programmable non-Cas enzymes for genome engineering, and gene therapy services leveraging these tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Proof Diagnostics company profile →
Cerexa
HQ: United States
Website
- Description: Provider of novel anti-infective therapies for serious and life-threatening infections; develops a portfolio of treatments including Ceftaroline Acetate/Ceftaroline, an injectable cephalosporin used for bacterial infections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cerexa company profile →
Clever Culture Systems
HQ: Switzerland
Website
- Description: Provider of intelligent image analysis solutions using artificial intelligence, including APAS Independence for automated microbial environmental monitoring with digital records, audit trails, standardized workflows and reduced human error, and MRSA and VRE Analysis Modules that automate detection on chromogenic media for efficient infection control by reporting negatives and triaging positives for review.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clever Culture Systems company profile →
Zavante
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical development of novel therapies to improve the outcomes of hospitalized patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zavante company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Resistell
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Resistell
2.2 - Growth funds investing in similar companies to Resistell
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Resistell
4.2 - Public trading comparable groups for Resistell
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →